Reanimation in Tetraplegia
Status: | Active, not recruiting |
---|---|
Conditions: | Hospital |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 21 - 89 |
Updated: | 8/31/2018 |
Start Date: | November 2013 |
End Date: | June 2019 |
The purpose of this clinical study is to allow the investigation of the Neural Bridging
System for participants with tetraplegia to assess if the investigational device can
reanimate a paralyzed limb under voluntary control by the participant's thoughts.
System for participants with tetraplegia to assess if the investigational device can
reanimate a paralyzed limb under voluntary control by the participant's thoughts.
This study plans to enroll participants who have been diagnosed with C4- C6 ASIA A spinal
cord injuries (motor and sensory complete neurologic injuries), who are more than 1 year post
injury, and who are neurologically stable.
cord injuries (motor and sensory complete neurologic injuries), who are more than 1 year post
injury, and who are neurologically stable.
Inclusion Criteria:
- Must be 21 years or older.
- Must be tetraplegic (C4- C6 ASIA A).
- 12 months post injury and neurologically stable.
- Participant is willing to comply with all follow-up evaluations at the specified
times.
- Participant is able to provide informed consent prior to enrollment in the study.
- The participant is fluent in English.
- Participant must have a caregiver willing to participate in the study who will provide
care for the surgical site.
Exclusion Criteria:
- No active wound healing or skin breakdown issues.
- No history of poorly controlled autonomic dysreflexia.
- Medical contraindications for general anesthesia, craniotomy, or surgery.
- Diagnosis of acute myocardial infarction or cardiac arrest within previous 6 months.
- Participants with any type of destruction and/or damage to the motor cortex region as
determined by MRI.
- History of psychiatric disturbance or dementia
- Other implantable devices such as heart/brain pacemakers
- Participants who rely on ventilators
- Co-morbid conditions that would interfere with study activities or response to
treatment.
- History of a neurological ablation procedure.
- Labeled contraindication for MRI.
- History of hemorrhagic stroke.
- History of HIV infection or ongoing chronic infection (such as tuberculosis).
- Pregnant or of child-bearing potential and are not taking acceptable methods of
contraception.
- Participation in another FDA device or medication trial that would interfere with the
current study.
We found this trial at
1
site
Columbus, Ohio 43210
Principal Investigator: Marcia Bockbrader, MD, PhD
Phone: 614-685-3141
Click here to add this to my saved trials